白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00874 白云山

交易中 08-14 14:41:14

15.130

-0.130

-0.85%

最高15.460	最低15.120	成交量37.20万
今开15.460	昨收15.260	日振幅2.23%
总市值246.01亿	流通市值33.27亿	总股本16.26亿
成交额564.68万	换手率0.17%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":15.13,"timestamp":1786689565252,"preClose":15.26,"halted":0,"volume":372000,"delay":0,"changeRate":-0.008519003931847903,"floatShares":219900000,"shares":1626000000,"eps":2.134670590081607,"marketStatus":"交易中","change":-0.13,"latestTime":"08-14 14:41:14","open":15.46,"high":15.46,"low":15.12,"amount":5646840,"amplitude":0.02228,"askPrice":15.16,"askSize":22000,"bidPrice":15.13,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":2.107840049215317,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1786695000000},"marketStatusCode":2,"adr":0,"listingDate":878140800000,"exchange":"SEHK","adjPreClose":15.26,"dividendRate":0.063139,"openAndCloseTimeList":[[1786671000000,1786680000000],[1786683600000,1786694400000]],"volumeRatio":0.754989,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":21.33,"timestamp":1786689672000,"preClose":21.51,"halted":0,"volume":6442000,"delay":0,"premium":"-39.02"}},"requestUrl":"/m/hq/s/00874","defaultTab":"news","newsList":[{"id":"2659150962","title":"白云山金装板蓝根颗粒（无蔗糖）重磅上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2659150962","media":"白云山官微","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659150962?lang=zh_cn&edition=full","pubTime":"2026-08-13 20:33","pubTimestamp":1786624380,"startTime":"0","endTime":"0","summary":"会上，白云山和黄中药重磅战略单品——白云山金装板蓝根颗粒（无蔗糖）正式发布上市，并面向全国零售连锁药店启动渠道招商。发布会现场，全国多家头部连锁及区域龙头药店负责人到场品鉴洽谈，普遍看好白云山金装板蓝根颗粒（无蔗糖）的赛道潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-08-13/doc-inineqhm3402402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0028","BK0175","600332","BK0012","BK1191","BK1197","BK1521","BK0239","BK0097","IPOS","BK1606","BK0096","BK0183","BK0196","BK1515","00874","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658091209","title":"股市必读：白云山新发布《H股公告（董事会召开日期）》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658091209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658091209?lang=zh_cn&edition=full","pubTime":"2026-08-12 01:40","pubTimestamp":1786470018,"startTime":"0","endTime":"0","summary":"公司公告汇总H股公告广州白云山医药集团股份有限公司董事会定于2026年8月21日举行会议，审议及批准公司及其附属公司截至2026年6月30日止六个月未经审计财务业绩。广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通知书的公告子公司广州白云山中一药业有限公司收到国家药品监督管理局签发的《药物临床试验批准通知书》，同意障眼明片开展用于干眼的临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600332","BK0183","BK0239","00874","BK0070","BK0097","BK0196","BK1191","BK1606","BK0028","BK0175","BK1515","BK0012","BK1197","BK0096","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115131220","title":"白云山（00874）子公司障眼明片获批开展干眼临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1115131220","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115131220?lang=zh_cn&edition=full","pubTime":"2026-08-10 18:40","pubTimestamp":1786358449,"startTime":"0","endTime":"0","summary":"2026年8月10日，广州白云山医药集团股份有限公司公告称，其全资子公司广州白云山中一药业有限公司已收到国家药品监督管理局签发的《药物临床试验批准通知书》，同意在完善方案后开展障眼明片新增“干眼”功能主治的临床试验。白云山提示，新增功能主治需在完成临床试验并经国家药品监督管理部门批准注册后方可写入说明书并用于临床。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658987532","title":"白云山：障眼明片获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2658987532","media":"南方财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658987532?lang=zh_cn&edition=full","pubTime":"2026-08-10 18:02","pubTimestamp":1786356120,"startTime":"0","endTime":"0","summary":"南财智讯8月10日电，白云山公告，障眼明片收到国家药品监督管理局核准签发的《药物临床试验批准通知书》（通知书编号：2026LP02273），同意其开展干眼的临床试验。该药为2.3类中药改良型新药，由子公司广州白云山中一药业有限公司申请，用于肝肾不足所致的干涩不舒、单眼复视、腰膝酸软或轻度视力下降等症，本次新增适应症为干眼。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608103836725458.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608103836725458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0096","BK0097","600332","BK0028","MDTX","BK0188","BK1606","PSYK","BK1191","IBBQ","BK1197","00874","BK0196","BK1521","BK0012","BK1515","BMED","BK0175","BK0183","BK0239","BK0070","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196812698","title":"白云山（00874）拟于2026年8月21日召开董事会审议中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1196812698","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196812698?lang=zh_cn&edition=full","pubTime":"2026-08-10 16:45","pubTimestamp":1786351536,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司（00874）8月10日公告称，公司董事会已排期于2026年8月21日（星期五）召开会议，主要议程包括：\n1. 审议及批准公司及其附属公司截至2026年6月30日止六个月的未经审计财务业绩；  \n2. 处理其他事项（如有）。\n董事会现由11名成员组成，其中执行董事6名，分别为陈杰辉、袁诚、程洪进、唐和平、刘漤及刘宏；非执行董事1名，为黄纪元；独立非执行董事4名，分别为黄龙德、孙宝清、吴向能及杨印宝。\n上述公告由公司董事会于2026年8月10日在中国广州发布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658608652","title":"股市必读：白云山新发布《广州白云山医药集团股份有限公司关于召开2026年第一次临时股东会的通知》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658608652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658608652?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:39","pubTimestamp":1786300750,"startTime":"0","endTime":"0","summary":"H股公告广州白云山医药集团股份有限公司将于2026年8月28日上午10时召开2026年第一次临时股东会，审议批准《董事、高级管理人员薪酬管理办法》及职工代表董事刘宏先生2026年度薪酬事项。H股股东名册将于2026年8月25日至8月28日暂停办理过户登记。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0188","BK0196","BK1515","BK0097","BK0012","BK0070","BK0175","BK0028","BK1606","BK1191","600332","BK0096","BK0239","00874","BK0183","159938","BK1161","BK1197","09939","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658759956","title":"每周股票复盘：白云山（600332）拟召开临时股东会审议董事薪酬议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2658759956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658759956?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:56","pubTimestamp":1786215371,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，白云山报收于21.5元，较上周的22.28元下跌3.5%。本周关注点公司公告汇总：白云山拟召开2026年第一次临时股东会，审议董事及高管薪酬管理办法及职工代表董事刘宏2026年度薪酬议案。H股股东名册将于2026年8月25日至8月28日暂停办理过户登记。股本股东变化广州白云山医药集团股份有限公司提交截至2026年7月31日的证券变动月报表，H股和A股的法定/注册股本及已发行股份均无变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0028","BK0188","BK0070","BK0183","BK0196","BK1521","BK1197","BK0239","BK0096","BK1191","BK0175","BK1606","600332","BK1515","00874","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657644762","title":"白云山（600332）披露召开2026年第一次临时股东会通知，8月7日股价上涨0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657644762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657644762?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:35","pubTimestamp":1786113317,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，白云山报收于21.5元，较前一交易日上涨0.51%，最新总市值为349.55亿元。该股当日开盘21.34元，最高21.52元，最低21.15元，成交额达1.76亿元，换手率为0.59%。近日，广州白云山医药集团股份有限公司发布关于召开2026年第一次临时股东会的通知。公告显示，公司将于2026年8月28日召开2026年第一次临时股东会，会议采用现场投票与网络投票相结合的方式，股权登记日为2026年8月24日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700041457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1521","00874","BK0196","BK0096","BK0183","BK0239","BK1197","BK1515","BK0012","BK0097","BK0028","BK0175","BK0188","BK0070","BK1606","600332","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157944076","title":"白云山（00874）将于2026年8月28日召开2026年第一次临时股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=1157944076","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157944076?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:36","pubTimestamp":1786091795,"startTime":"0","endTime":"0","summary":"白云山8月7日发布公告称，公司第十届董事会第三次会议已审议并通过召开2026年第一次临时股东大会的议案。临时股东大会定于2026年8月28日（星期五）上午10:00，于中国广东省广州市荔湾区沙面北街45号公司会议室举行。为确定有权出席并投票的H股股东身份，公司H股股东名册将于2026年8月25日至2026年8月28日暂停股份过户登记。股东须在2026年8月24日16:30或之前，向香港中央证券登记有限公司递交过户文件及相关股票，方可列入股东名册。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657689302","title":"白云山：持续推进“一品牌一策略”精细化运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2657689302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657689302?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:01","pubTimestamp":1786006860,"startTime":"0","endTime":"0","summary":"证券之星消息，白云山(600332)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：公司有王老吉超级品牌，陈李济等众多老字号品牌，没有好好开发，一手好牌没人会打，可惜了，近两年业绩接连下降，市值不断萎缩，请问公司如何应对？白云山回复：尊敬的投资者您好，感谢您的关注！公司重视王老吉、陈李济等品牌价值挖掘，持续推进 \"一品牌一策略\" 精细化运营。公司将持续提升经营质量，以稳定的业绩增长和分红回报投资者，同时将继续积极传递公司价值，做好市值管理工作。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600027797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600332","00874","BK0028","BK0097","BK0096","BK0175","BK0012","BK0188","BK1606","BK1191","BK1197","BK1515","BK0239","BK1521","BK0183","BK0070","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657307689","title":"白云山：公司控股股东广药集团在2026年《财富》世界500强企业中位列第467位","url":"https://stock-news.laohu8.com/highlight/detail?id=2657307689","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657307689?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:00","pubTimestamp":1786006841,"startTime":"0","endTime":"0","summary":"证券之星消息，白云山(600332)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好！2026年《财富》世界500强企业最新发布，公司是否位列排行之中？谢谢回复！白云山回复：尊敬的投资者您好！公司控股股东广药集团在2026年《财富》世界500强企业中位列第467位。白云山为广药集团控股的上市公司。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600027792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","600332","BK1191","BK0175","BK1197","BK0196","BK1606","BK1515","BK0070","BK1521","BK0012","BK0183","00874","BK0188","BK0097","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521957","title":"股市必读：白云山新发布《广州白云山医药集团股份有限公司关于子公司《药品生产许可证》变更的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657521957?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:34","pubTimestamp":1785951251,"startTime":"0","endTime":"0","summary":"H股公告广州白云山医药集团股份有限公司提交截至2026年7月31日的证券变动月报表，显示公司H股和A股的法定/注册股本及已发行股份均无变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600332","BK0183","BK1161","159938","BK1574","BK1606","BK1515","BK0096","00874","BK0175","BK1521","BK1197","BK0097","BK1191","BK0196","BK0012","BK0188","BK0028","BK0239","09939","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169932329","title":"白云山（00874）子公司中一药业《药品生产许可证》变更获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1169932329","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169932329?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:57","pubTimestamp":1785833866,"startTime":"0","endTime":"0","summary":"2026年8月4日，广州白云山医药集团股份有限公司公告称，其全资子公司广州白云山中一药业有限公司已收到广东省药品监督管理局核准签发的新《药品生产许可证》，许可证编号为“粤20160046”，有效期至2030年3月29日。公告亦提示，受医药行业市场环境等因素影响，药品生产和销售存在不确定性，提醒投资者注意相关风险。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142094159","title":"白云山7月股份变动月报表：股本维持1,625,790,949股不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1142094159","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142094159?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:57","pubTimestamp":1785833844,"startTime":"0","endTime":"0","summary":"广州白云山医药集团股份有限公司于2026年8月4日发布截至2026年7月31日的股份变动月报表。公告显示，报告期内公司股本结构及已发行股份数量保持稳定，未发生新增发行、购回、注销或库藏股变动。上述两类股份数量与上月相比均无变化，发行股份总数继续保持在1,625,790,949股。本次月报由公司秘书黄雪贞于2026年8月4日签署提交。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656056535","title":"白云山：子公司药品生产许可证变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2656056535","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656056535?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:09","pubTimestamp":1785830940,"startTime":"0","endTime":"0","summary":"南财智讯8月4日电，白云山公告，子公司广州白云山中一药业有限公司取得广东省药品监督管理局换发的《药品生产许可证》，同意《药品生产许可证》的变更申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608043831191731.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608043831191731.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","BK1515","00874","BK0012","BK1521","BK0070","BK0096","BK0097","BK1197","BK1606","BK0196","BK0183","600332","BK1191","BK0028","BK0239","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656985348","title":"股市必读：白云山新发布《关于兴业圆融-广州医药应收账款4期资产支持专项计划清算的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656985348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656985348?lang=zh_cn&edition=full","pubTime":"2026-08-03 01:05","pubTimestamp":1785690311,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，白云山报收于22.28元，上涨0.36%，换手率0.86%，成交量12.1万手，成交额2.67亿元。当日关注点交易信息汇总：7月31日主力资金净流入2014.43万元，占总成交额7.54%。公司公告汇总：兴业圆融-广州医药应收账款4期资产支持专项计划已于2026年7月17日清算完毕，专项计划账户余额为0.00元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300000419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","00874","BK0188","BK1161","BK0196","09939","BK0096","600332","BK1197","BK0028","BK1606","BK0097","BK1515","BK0175","BK0070","BK1574","BK0183","159938","BK0239","BK1521","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656316575","title":"每周股票复盘：白云山（600332）应收账款ABS清算完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2656316575","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656316575?lang=zh_cn&edition=full","pubTime":"2026-08-02 01:42","pubTimestamp":1785606133,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，白云山报收于22.28元，较上周的21.59元上涨3.2%。本周，白云山7月31日盘中最高价报22.3元。白云山当前最新总市值362.23亿元，在中药板块市值排名4/66，在两市A股市值排名529/5202。本周关注点公司公告汇总：兴业圆融-广州医药应收账款4期资产支持专项计划已清算完毕，账户余额为0.00元。截至2026年7月17日，专项计划账户余额为0.00元，清算完毕后将启动托管户销户。管理人聘请毕马威华振会计师事务所进行清算审计并出具报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","BK0012","BK0196","BK0175","600332","BK1197","BK1521","BK0028","BK1191","BK1515","BK0183","BK0188","BK0097","BK1606","BK0070","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169636650","title":"白云山（00874）披露第四期应收账款资产支持专项计划清算公告","url":"https://stock-news.laohu8.com/highlight/detail?id=1169636650","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169636650?lang=zh_cn&edition=full","pubTime":"2026-07-31 17:13","pubTimestamp":1785489193,"startTime":"0","endTime":"0","summary":"2026年7月31日，广州白云山医药集团股份有限公司在香港交易所发布海外监管公告称，公司已在上海证券交易所网站披露《兴业圆融－广州医药应收账款4期资产支持专项计划清算的公告》。根据公告披露，上述信息系依据香港联合交易所有限公司证券上市规则第13.10B条进行的刊载。公告显示，该专项计划的清算事项已经完成。本次公告未披露其他财务数据。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654052425","title":"每周股票复盘：白云山（600332）现615.37万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2654052425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654052425?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:47","pubTimestamp":1785001632,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，白云山报收于21.59元，较上周的22.18元下跌2.66%。本周，白云山7月21日盘中最高价报22.72元。7月24日盘中最低价报21.55元。白云山当前最新总市值351.01亿元，在中药板块市值排名4/66，在两市A股市值排名528/5200。该药品适用于敏感菌所致的呼吸道、尿路及皮肤软组织感染。2025年国内销售额为2,472万元，白云山制药总厂当年销售收入为450万元，研发费用累计约789万元。此次获批有助于拓展境外市场，对当期业绩无重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK1515","BK1521","BK0196","BK1606","BK0070","BK1197","BK0239","BK0096","00874","BK0097","BK1191","BK0012","BK0175","600332","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653296746","title":"白云山：公司目前暂无股份回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2653296746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653296746?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:09","pubTimestamp":1784801368,"startTime":"0","endTime":"0","summary":"证券之星消息，白云山07月23日在投资者关系平台上答复投资者关心的问题。公司目前暂无股份回购计划，相关信息请以公司公开披露的信息为准；公司通过接待投资者调研、业绩路演、举办网上业绩说明会等多种方式与投资者进行沟通，我们将继续积极传递公司价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300037530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0196","BK0096","BK0175","BK0097","BK0183","BK1191","BK0070","BK1197","BK1606","00874","BK0188","BK1521","BK1515","600332","BK0012"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gybys.com.cn","stockEarnings":[{"period":"1week","weight":-0.0084},{"period":"1month","weight":-0.0136},{"period":"3month","weight":-0.0488},{"period":"6month","weight":-0.1776},{"period":"1year","weight":-0.1098},{"period":"ytd","weight":-0.109}],"compareEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":0.0434},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.0441},{"period":"1year","weight":-0.0085},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.009956},{"month":2,"riseRate":0.714286,"avgChangeRate":0.058376},{"month":3,"riseRate":0.586207,"avgChangeRate":0.049652},{"month":4,"riseRate":0.62069,"avgChangeRate":0.081835},{"month":5,"riseRate":0.551724,"avgChangeRate":0.044342},{"month":6,"riseRate":0.482759,"avgChangeRate":0.019085},{"month":7,"riseRate":0.448276,"avgChangeRate":-0.011403},{"month":8,"riseRate":0.37931,"avgChangeRate":-0.037038},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.010726},{"month":10,"riseRate":0.428571,"avgChangeRate":0.004047},{"month":11,"riseRate":0.448276,"avgChangeRate":0.008322},{"month":12,"riseRate":0.535714,"avgChangeRate":0.023783}],"exchange":"SEHK","name":"白云山","nameEN":"BAIYUNSHAN PH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,00874,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}